These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18398385)

  • 21. Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine.
    Ochiai M; Horiuchi Y; Yuen CT; Asokanathan C; Yamamoto A; Okada K; Kataoka M; Markey K; Corbel M; Xing D
    Hum Vaccin Immunother; 2014; 10(7):2074-80. PubMed ID: 25424818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children.
    Bose A; Dubey AP; Gandhi D; Pandit A; Raghu MB; Raghupathy P; Rao MI; Verghese VP; Datta SK; Bock HL
    Indian Pediatr; 2007 Jun; 44(6):421-4. PubMed ID: 17620694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1078-9. PubMed ID: 18830212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.
    Robbins JB; Schneerson R; Trollfors B; Sato H; Sato Y; Rappuoli R; Keith JM
    J Infect Dis; 2005 Jan; 191(1):81-8. PubMed ID: 15593007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4-6 years of age--a comparison of two vaccines with different amounts of diphtheria toxoid.
    Thierry-Carstensen B; Sjølin Frederiksen M; Andersen PH; Stellfeld M
    Vaccine; 2004 Dec; 23(5):668-71. PubMed ID: 15542188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study.
    Jackson LA; Yu O; Nelson J; Belongia EA; Hambidge SJ; Baxter R; Naleway A; Nordin J; Baggs J; Iskander J
    Vaccine; 2009 Aug; 27(36):4912-6. PubMed ID: 19567245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands.
    Keijzer-Veen MG; Holty-van der Wekken L; Juttmann RE; de Groot R; Rümke HC
    Vaccine; 2004 Sep; 22(25-26):3256-7. PubMed ID: 15308347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection site and risk of medically attended local reactions to acellular pertussis vaccine.
    Jackson LA; Yu O; Nelson JC; Dominguez C; Peterson D; Baxter R; Hambidge SJ; Naleway AL; Belongia EA; Nordin JD; Baggs J;
    Pediatrics; 2011 Mar; 127(3):e581-7. PubMed ID: 21300679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Booster vaccination of toddlers with reduced antigen content diphtheria -- tetanus -- acellular pertussis vaccine.
    Nolan T; Ruff TA; Lambert SB; Buttery J; O'Grady KA; Streeton C; Hoet B; Bock HL
    Vaccine; 2009 Apr; 27(18):2410-3. PubMed ID: 19368781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine.
    Barreto L; Guasparini R; Meekison W; Noya F; Young L; Mills E
    Vaccine; 2007 Nov; 25(48):8172-9. PubMed ID: 17945400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
    Carbone T; McEntire B; Kissin D; Kelly D; Steinschneider A; Violaris K; Karamchandani N
    Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protein content of diphtheria-tetanus toxoids-acellular pertussis vaccines and an emerging clinical problem.
    Cherry JD
    J Infect Dis; 2005 Apr; 191(8):1386-8. PubMed ID: 15776394
    [No Abstract]   [Full Text] [Related]  

  • 36. Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact.
    Skowronski DM; Remple VP; Macnabb J; Pielak K; Patrick DM; Halperin SA; Scheifele D
    Pediatrics; 2003 Dec; 112(6 Pt 1):e453. PubMed ID: 14654644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions.
    Rennels MB; Deloria MA; Pichichero ME; Englund JA; Anderson EL; Steinhoff MC; Decker MD; Edwards KM
    Vaccine; 2002 May; 20 Suppl 3():S44-7. PubMed ID: 12184364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1079-80. PubMed ID: 18830213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of dTPa.
    Luiz N
    Indian Pediatr; 2007 Nov; 44(11):869; author reply 870-1. PubMed ID: 18057492
    [No Abstract]   [Full Text] [Related]  

  • 40. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.